Evidence map›Paper›PMID 25422130›Full record

ArticleInternational journal of oncology2015

Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.

Shota Moriya, Seiichiro Komatsu, Kaho Yamasaki, Yusuke Kawai, Hiroko Kokuba, Ayako Hirota, Xiao-Fang Che, Masato Inazu, Akihiko Gotoh, Masaki Hiramoto and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Oncology letters · 2024
    Article
  9. Article
  10. Review
  11. Autophagy-related mechanisms for treatment of multiple myeloma.Cancer drug resistance (Alhambra, Calif.) · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shota MoriyaDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Seiichiro KomatsuDepartment of Breast Oncology, Tokyo Medical University, Tokyo, Japan.
Kaho YamasakiDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Yusuke KawaiDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Hiroko KokubaLaboratory of Electron Microscopy, Tokyo Medical University, Tokyo, Japan.
Ayako HirotaDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Xiao-Fang CheDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Masato InazuInstitute of Medical Science, Tokyo Medical University, Tokyo, Japan.
Akihiko GotohDepartment of Hematology, Juntendo University, Tokyo, Japan.
Masaki HiramotoDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Keisuke MiyazawaDepartment of Biochemistry, Tokyo Medical University, Tokyo, Japan.
Tokyo Medical University · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inhibitory effects of macrolide antibiotics including clarithromycin (CAM) on autophagy flux have been reported. Although a macrolide antibiotic exhibits no cytotoxicity, its combination with bortezomib (BZ), a proteasome inhibitor, for the simultaneous blocking of the ubiquitin (Ub)‑proteasome and autophagy‑lysosome pathways leads to enhanced multiple myeloma (MM) cell apoptosis induction via stress overloading of the endoplasmic reticulum (ER). As misfolded protein cargo is recruited by histone deacetylase 6 (HDAC6) to dynein motors for aggresome transport, serving to sequester misfolded proteins, we further investigated the cellular effects of targeting proteolytic pathways and aggresome formation concomitantly in MM cells. Pronounced apoptosis was induced by the combination of vorinostat [suberoylanilide hydroxamic acid (SAHA); potently inhibits HDAC6] with CAM and BZ compared with each reagent or a 2‑reagent combination. CAM/BZ treatment induced vimentin positive‑aggresome formation along with the accumulation of autolysosomes in the perinuclear region, whereas they were inhibited in the presence of SAHA. The SAHA/CAM/BZ combination treatment maximally upregulated genes related to ER stress including C/EBP homologous protein (CHOP). Similarly to MM cell lines, enhanced cytotoxicity with CHOP upregulation following SAHA/CAM/BZ treatment was shown by a wild‑type murine embryonic fibroblast (MEF) cell line; however, a CHOP‑deficient MEF cell line almost completely canceled this pronounced cytotoxicity. Knockdown of HDAC6 with siRNA exhibited further enhanced CAM/BZ‑induced cytotoxicity and CHOP induction along with the cancellation of aggresome formation. Targeting the integrated networks of aggresome, proteasome, and autophagy is suggested to induce efficient ER stress‑mediated apoptosis in MM cells.

Indexed as

AnimalsAntineoplastic Combined Chemotherapy ProtocolsApoptosisAutophagyBoronic AcidsBortezomibCell Line, TumorClarithromycinDrug SynergismEndoplasmic ReticulumEndoplasmic Reticulum StressHistone Deacetylase 6Histone DeacetylasesHumansHydroxamic AcidsMiceBoronic AcidsBortezomibClarithromycinHDAC6 protein, humanHistone Deacetylase 6Histone DeacetylasesHydroxamic AcidsProteasome Endopeptidase ComplexPyrazinesVorinostat

Identifiers

PMID25422130
PMCPMC4277245
OpenAlexW2065234653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.